Diagnosis of rare inherited diseases

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

Abstract

Delineation of the genetic basis of rare inherited diseases can provide diagnostic certainty and risk assessment for affected individuals and their families. Determination of the genes that are mutated in such conditions can not only provide important insights into disease pathogenesis, but have frequently been shown to shed important light on the molecular pathology of common complex disorders, which share similar features. Crucially, disease gene identification represents the starting point for the development of novel therapeutics. This chapter describes the different types of genetic disorders – both chromosomal and monogenic – and the advances in technology, including next generation sequencing and microarrays that are driving the discovery of novel genetic mechanisms underlying human disease.
Original languageEnglish
Title of host publicationOrphan Drugs and Rare Diseases
EditorsDavid C. Pryde, Michael Palmer
Place of PublicationCambridge
PublisherRoyal Society of Chemistry
Chapter2
Pages35-49
Number of pages15
ISBN (Electronic)9781782624202, 9781782622901
ISBN (Print)9781849738064
DOIs
Publication statusPublished - 30 Jul 2014

Publication series

NameRSC Drug Discovery Series
PublisherThe Royal Society of Chemistry
Volume38
ISSN (Print)2041-3203

Fingerprint

Dive into the research topics of 'Diagnosis of rare inherited diseases'. Together they form a unique fingerprint.

Cite this